MINSK, 20 July (BelTA) - Belarusian Nativita and Hungarian Pharma Gap Kft have signed an agreement of intent of cooperation, BelTA learned from the Belarusian Embassy in Hungary which hosted the signing ceremony.
“The companies are planning to register and distribute vital Belarus-made medicines in Hungary and other countries. The list of drugs includes cancer medicines and the drugs to calm a cytokine storm in COVID-19,” the embassy said.
Nativita is an international pharmaceutical R&D company developing and producing innovative drugs for the treatment of cancer, autoimmune and other serious diseases at the GMP certified production facilities in Belarus. “Since 2016, Nativita has been among top five companies on the hospital market of Belarus and has become the number one company in the cancer segment. Deep localization and certified full-cycle production of medications creates good opportunities for increasing exports of Belarusian medicines to the EU,” said the Belarusian diplomatic mission.
